CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...